Scar Treatment Industry Overview
The global scar treatment market size was estimated at USD 2.32 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2030. The market is expected to grow due to several factors, such as the growing concern among people regarding their aesthetic appearance, the increasing number of road accidents and burn injuries, and technological advancements supplementing new device launches. The first two waves of the COVID-19 pandemic were marked by the rapid adoption of telemedicine in all domains of the healthcare sector. Skincare, being non-emergency, requires minimal hospital visits. Even though final procedures require a patient to visit the hospital or doctor’s office, pre-planning and post-procedure management were largely preferred through telemedicine.
Gather more insights about the market drivers, restrains and growth of the Scar Treatment Market
The COVID-19 pandemic impeded the market growth in 2020, but the trends of telemedicine are expected to play an important role in optimizing the market growth as compared to the pre-COVID period. In addition, the adoption of ambulatory surgery centers and the development of portable or mobile scar treatment devices are expected to boost the growth of the market in both developed as well as developing regions.
The market is experiencing immense technological developments with the introduction of laser therapy, for instance, MedLite C6, a Q-switched laser-based instrument developed for treating acne. Laser instruments help destroy scar tissue, thereby assisting in scar treatment procedures. Treatment with laser products involves both surgical and nonsurgical procedures. Plastic and reconstructive surgery is also a part of the surgical laser treatment process. For instance, in June 2022, Cynosure launched PicoSure Pro Device to treat wrinkles, acne scars, and pores.
According to a report by the American Society of Plastic Surgeons in 2022, nearly 50,930 scar revision procedures were performed in 2022 in the U.S. Hence, the demand for greater aesthetic appeal plays an important role in increasing the number of reconstructive surgical cases for scar revision. In addition to skin corrective surgeries, scar treatment products are also widely adopted.
Scar Treatment Market Segmentation
Grand View Research has segmented the global scar treatment market report based on product, scar type, end-use, and region:
Scar Treatment Product Outlook (Revenue, USD Million, 2018 – 2030)
• Topical Products
o Creams
o Gels
o Silicon Sheets
o Others
• Laser Products
o CO2 Laser
o Pulse-dyed Laser
o Others
• Injectables
• Others
Scar Treatment Scar Type Outlook (Revenue, USD Million, 2018 – 2030)
• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks
Scar Treatment End-use Outlook (Revenue, USD Million, 2018 – 2030)
• Hospitals
• Clinics
• Homecare
Scar Treatment Regional Outlook (Revenue, USD Million, 2018 – 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Denmark
o Norway
o Sweden
• Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Mexico
o Argentina
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the Scar Treatment Market Intelligence Study, published by Grand View Research.
Key Companies profiled:
• Smith & Nephew PLC
• Lumenis
• Enaltus LLC
• Merz Pharmaceuticals, LLC
• Sonoma Pharmaceuticals, Inc.
• Cynosure
• Scar Heal Inc.
• CCA Industries, Inc.
• Newmedical Technology Inc.
• Mölnlycke Health Care AB
• Suneva Medical
• Pacific World Corporation
• Perrigo Company plc